Log in

NASDAQ:ALEC - Alector Stock Price, Forecast & News

$22.76
-1.99 (-8.04 %)
(As of 03/29/2020 04:00 PM ET)
Today's Range
$22.76
Now: $22.76
$24.88
50-Day Range
$21.09
MA: $28.33
$35.28
52-Week Range
$13.64
Now: $22.76
$35.93
Volume389,899 shs
Average Volume627,039 shs
Market Capitalization$1.79 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Alector, Inc., a clinical stage biotechnology company, focuses on developing therapies that harness the immune system to cure neurodegenerative diseases. Its products in Phase I clinical trial include AL001, a humanized recombinant monoclonal antibody for the treatment of frontotemporal dementia; and AL002 for the treatment of Alzheimer's disease. The company's preclinical stage products comprise AL101 for the treatment of multiple neurodegenerative disorders; and AL003 for the treatment of Alzheimer's disease. It also has 10 programs under research and development stage. The company was founded in 2013 and is headquartered in South San Francisco, California.
Read More

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ALEC
CUSIPN/A
CIKN/A
Phone415-231-5660

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$21.22 million

Profitability

Net Income$-52,250,000.00
Net Margins-496.65%

Miscellaneous

Employees91
Market Cap$1.79 billion
Next Earnings Date5/11/2020 (Estimated)
OptionableNot Optionable

Receive ALEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ALEC and its competitors with MarketBeat's FREE daily newsletter.


Alector (NASDAQ:ALEC) Frequently Asked Questions

How has Alector's stock been impacted by COVID-19 (Coronavirus)?

Alector's stock was trading at $24.92 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ALEC stock has decreased by 8.7% and is now trading at $22.76. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Alector?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alector.

When is Alector's next earnings date?

Alector is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Alector.

How were Alector's earnings last quarter?

Alector Inc (NASDAQ:ALEC) announced its quarterly earnings results on Tuesday, March, 24th. The company reported ($0.45) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.48) by $0.03. The company earned $6 million during the quarter, compared to analysts' expectations of $9.60 million. Alector had a negative net margin of 496.65% and a negative return on equity of 45.56%. View Alector's earnings history.

What price target have analysts set for ALEC?

5 brokerages have issued 12 month target prices for Alector's stock. Their forecasts range from $28.00 to $28.00. On average, they anticipate Alector's stock price to reach $28.00 in the next twelve months. This suggests a possible upside of 23.0% from the stock's current price. View analysts' price targets for Alector.

Has Alector been receiving favorable news coverage?

News articles about ALEC stock have trended extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Alector earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutAlector.

Who are some of Alector's key competitors?

What other stocks do shareholders of Alector own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Advanced Micro Devices (AMD), AT&T (T), Verizon Communications (VZ), Johnson & Johnson (JNJ), Gossamer Bio (GOSS) and Kaleido Biosciences (KLDO).

Who are Alector's key executives?

Alector's management team includes the following people:
  • Dr. Tillman U. Gerngross, Co-Founder & Chairman (Age 55)
  • Dr. Arnon Rosenthal, Co-Founder, CEO, Pres & Director (Age 64)
  • Dr. Robert Paul M.D., Ph.D., Chief Medical Officer (Age 51)
  • Dr. Robert S. King, Chief Devel. Officer (Age 56)
  • Dr. Asa Abeliovich M.D., Ph.D., Co-Founder

When did Alector IPO?

(ALEC) raised $177 million in an initial public offering (IPO) on Thursday, February 7th 2019. The company issued 9,300,000 shares at a price of $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays served as the underwriters for the IPO.

What is Alector's stock symbol?

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Who are Alector's major shareholders?

Alector's stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (3.42%), Casdin Capital LLC (1.56%), State Street Corp (1.51%), Franklin Resources Inc. (1.15%), Franklin Resources Inc. (1.15%) and Marshall Wace North America L.P. (1.01%). Company insiders that own Alector stock include Calvin Yu, David M Wehner, Orbimed Advisors Llc, Robert King, Robert Paul and Sabah Oney. View institutional ownership trends for Alector.

Which institutional investors are selling Alector stock?

ALEC stock was sold by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Bamco Inc. NY, Spark Investment Management LLC, UBS Group AG, and Nuveen Asset Management LLC. Company insiders that have sold Alector company stock in the last year include Calvin Yu, Orbimed Advisors Llc, Robert King, Robert Paul, and Sabah Oney. View insider buying and selling activity for Alector.

Which institutional investors are buying Alector stock?

ALEC stock was bought by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Pictet Asset Management Ltd., State Street Corp, FMR LLC, Casdin Capital LLC, Franklin Resources Inc., Franklin Resources Inc., and Oppenheimer & Co. Inc.. Company insiders that have bought Alector stock in the last two years include David M Wehner, and Orbimed Advisors Llc. View insider buying and selling activity for Alector.

How do I buy shares of Alector?

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Alector's stock price today?

One share of ALEC stock can currently be purchased for approximately $22.76.

How big of a company is Alector?

Alector has a market capitalization of $1.79 billion and generates $21.22 million in revenue each year. The company earns $-52,250,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Alector employs 91 workers across the globe. View additional information about Alector.

What is Alector's official website?

The official website for Alector is http://www.alector.com/.

How can I contact Alector?

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]


MarketBeat Community Rating for Alector (NASDAQ ALEC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  108 (Thanks for Voting!)
Underperform Votes:  110 (Thanks for Voting!)
Total Votes:  218
MarketBeat's community ratings are surveys of what our community members think about Alector and other stocks. Vote "Outperform" if you believe ALEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALEC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel